Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 2, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Akoya Biosciences, Inc.
| -14.27K |
$4.56 | -$65,080.32 | -7.32% | 180.73K |
Apr 1
| |||||||
Akoya Biosciences, Inc.
| 35K |
—
|
—
| +21.88% | 195K |
Feb 22
| |||||||
Akoya Biosciences, Inc.
| 20K |
$5.00 | $100,000.00 |
∞
| 20K |
Jun 12
| |||||||
Akoya Biosciences, Inc.
| 160K |
—
|
—
|
∞
| 160K |
Mar 20
| |||||||
Akoya Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Genmark Diagnostics, Inc.
| -232.99K |
$24.05 | -$5,603,481.65 | -100.00% |
0
|
Apr 22
| |||||||
Genmark Diagnostics, Inc.
| -19.25K |
—
|
—
| -7.63% | 232.99K |
Feb 25
| |||||||
Genmark Diagnostics, Inc.
| -908.00 |
—
|
—
| -0.36% | 252.24K |
Feb 23
| |||||||
Genmark Diagnostics, Inc.
| -487.00 |
—
|
—
| -0.19% | 253.15K |
Feb 21
| |||||||
Genmark Diagnostics, Inc.
| 43.38K |
—
|
—
| +20.63% | 253.64K |
Feb 18
| |||||||
Genmark Diagnostics, Inc.
| 31.97K |
$14.24 | -$263,084.00 | +17.93% | 210.26K |
Jan 21 - Jan 25
| |||||||
Genmark Diagnostics, Inc.
| -1.42K |
$13.17 | -$18,675.06 | -0.79% | 178.28K |
Nov 24
| |||||||
Genmark Diagnostics, Inc.
| -1.64K |
$13.85 | -$22,672.45 | -0.90% | 179.7K |
Nov 19
| |||||||
Genmark Diagnostics, Inc.
| -41.20K |
$13.82 | -$569,328.72 | -18.51% | 181.34K |
Sep 22
|
Scheduled
| ||||||
Genmark Diagnostics, Inc.
| -5.72K |
$12.98 | -$74,284.54 | -2.51% | 222.53K |
Sep 16
|
Scheduled
| ||||||
Genmark Diagnostics, Inc.
| -1.51K |
$14.14 | -$21,422.10 | -0.66% | 228.26K |
Aug 25
| |||||||
Genmark Diagnostics, Inc.
| -2.59K |
$15.60 | -$40,431.31 | -1.12% | 229.77K |
Aug 20
|
Scheduled
| ||||||
Genmark Diagnostics, Inc.
| -33.38K |
$15.98 | -$533,313.76 | -12.56% | 232.36K |
Aug 14 - Aug 18
|
Scheduled
| ||||||
Genmark Diagnostics, Inc.
| -1.46K |
$9.52 | -$13,899.20 | -0.55% | 265.74K |
May 28
| |||||||
Genmark Diagnostics, Inc.
| -1.65K |
$10.46 | -$17,238.08 | -0.61% | 267.2K |
May 19
| |||||||
Genmark Diagnostics, Inc.
| -1.04K |
$3.51 | -$3,650.40 | -0.39% | 268.85K |
Feb 27
| |||||||
Genmark Diagnostics, Inc.
| 104.48K |
$3.81 | -$1,965.96 | +63.17% | 269.89K |
Feb 25
| |||||||
Genmark Diagnostics, Inc.
| -8.85K |
$3.80 | -$33,622.40 | -5.08% | 165.41K |
Feb 20
| |||||||
Genmark Diagnostics, Inc.
| 3.46K |
$4.80 | -$13,214.40 | +2.03% | 174.25K |
Jan 21
| |||||||
Genmark Diagnostics, Inc.
| -1.42K |
$5.43 | -$7,710.60 | -0.82% | 170.79K |
Nov 25
| |||||||
Genmark Diagnostics, Inc.
| -489.00 |
$5.55 | -$2,713.95 | -0.28% | 172.21K |
Nov 20
| |||||||
Genmark Diagnostics, Inc.
| -1.44K |
$6.03 | -$8,677.17 | -0.83% | 172.7K |
Aug 27
| |||||||
Genmark Diagnostics, Inc.
| -510.00 |
$6.25 | -$3,187.50 | -0.29% | 174.14K |
Aug 20
| |||||||
Genmark Diagnostics, Inc.
| -1.89K |
$5.87 | -$11,094.30 | -1.07% | 174.65K |
Aug 5
| |||||||
Genmark Diagnostics, Inc.
| -924.00 |
$6.60 | -$6,098.40 | -0.52% | 176.54K |
May 30
| |||||||
Genmark Diagnostics, Inc.
| -501.00 |
$6.85 | -$3,431.85 | -0.28% | 177.46K |
May 23
| |||||||
Genmark Diagnostics, Inc.
| -495.00 |
$6.83 | -$3,380.85 | -0.28% | 177.96K |
May 21
| |||||||
Genmark Diagnostics, Inc.
| -5.21K |
$6.79 | -$35,341.95 | -2.83% | 178.46K |
Feb 25
| |||||||
Genmark Diagnostics, Inc.
| 74.41K |
$6.16 | -$3,665.20 | +68.10% | 183.66K |
Feb 18 - Feb 20
| |||||||
Genmark Diagnostics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.